Pfizer

News

EU regulators approve AstraZeneca's Lynparza in pancreatic c...

The European Commission has approved AstraZeneca and MSD’s Lynparza (olaparib) in pancreatic cancer patients with a certain mutation.

News

Pfizer/BioNTech's COVID-19 vaccine neutralises virus in earl...

Pfizer and BioNTech have announced early results from their ongoing phase 1 /2 study of a potential COVID-19 coronavirus vaccine, showing the jab seems to be working in a small sample of pa

News

Close up of woman hands holding a pills.

SidekickHealth launches gamified meds management platform wi...

Pfizer and Nordic digital therapeutics firm SidekickHealth have launched a gamified digital medication management and lifestyle platform across Europe in a deal thought to be worth more tha

Partner Content

Personal Protective Equipment for Infection Control Market

Partner Content

PPE for Infection Control Market Will Touch $17.1 Billion By...

Global Market Insights, Inc., report forecasts the personal protective equipment for infection control industry to grow at a CAGR of -19.3 per cent through 2026.

Partner Content

Dermatology Devices Market Size Will Achieve 11.9% CAGR From...

The global dermatology devices market size is expected to reach USD 20 billion by 2025, at a CAGR of 11.9% during the forecast period 2019 to 2025.

Partner Content

Hand Sanitizer Market will touch USD 3.6 billion by 2026

Global Hand Sanitizer Market size is projected to surpass USD 3.6 billion through 2026, growing at a CAGR of -2.4% for the period spanning from 2020 to 2026.

EU regulators approve AstraZeneca's Lynparza in pancreatic c...

Pfizer/BioNTech's COVID-19 vaccine neutralises virus in earl...

SidekickHealth launches gamified meds management platform wi...

PPE for Infection Control Market Will Touch $17.1 Billion By...

Dermatology Devices Market Size Will Achieve 11.9% CAGR From...

Hand Sanitizer Market will touch USD 3.6 billion by 2026

Takeda’s Innovent deal bears fruit, with Teresa Bitetti and ...

Discover a new era of healthcare panel engagement: Grounded ...

Pfizer

Editor's Picks